Affinium Pharmaceuticals Ltd.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 2000-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.afnm.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)A Study of Safety, Tolerability, and Efficacy of AFN-12520000 in the Treatment of Acute Bacterial Skin and Skin Structure Infections Due to Staphylococci
Phase 2
Completed
- Conditions
- Skin and Subcutaneous Tissue Bacterial InfectionsWound InfectionCutaneous AbscessBurn InfectionCellulitis
- Interventions
- First Posted Date
- 2012-01-27
- Last Posted Date
- 2012-08-07
- Lead Sponsor
- Affinium Pharmaceuticals, Ltd
- Target Recruit Count
- 103
- Registration Number
- NCT01519492
- Locations
- 🇺🇸
SITE 018, Buena Park, California, United States
🇺🇸SITE 005, Chula Vista, California, United States
🇺🇸SITE 001, La Mesa, California, United States
News
No news found